Compare PGEN & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | SMTI |
|---|---|---|
| Founded | 1998 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 186.9M |
| IPO Year | N/A | N/A |
| Metric | PGEN | SMTI |
|---|---|---|
| Price | $4.62 | $25.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.67 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 5.4M | 43.0K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,309,000.00 | ★ $101,877,532.00 |
| Revenue This Year | $342.78 | $21.60 |
| Revenue Next Year | $478.46 | $16.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 59.20 | 30.52 |
| 52 Week Low | $1.05 | $18.90 |
| 52 Week High | $5.23 | $38.68 |
| Indicator | PGEN | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 55.80 |
| Support Level | $4.01 | $22.60 |
| Resistance Level | $4.95 | $25.06 |
| Average True Range (ATR) | 0.32 | 0.92 |
| MACD | 0.06 | 0.09 |
| Stochastic Oscillator | 67.14 | 69.74 |
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.